mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |